+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Artificial Intelligence in Life Sciences Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6123147
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Artificial Intelligence in Life Sciences Market is projected to reach USD 12.94 Billion in 2026. It is expected to continue growing at a CAGR of 17.95%, reaching USD 35.25 Billion by 2032.

Artificial Intelligence in Life Sciences: Executive Overview

Artificial intelligence is reshaping life sciences by supporting discovery, clinical development, manufacturing, diagnostics, and healthcare delivery. Its value is emerging through faster analysis of complex biological and clinical data, improved decision support, automation of repetitive work, and more personalized approaches to care. Adoption remains dependent on evidence quality, regulatory alignment, data access, cybersecurity, interoperability, and workforce readiness.

From Experimental Pilots to Governed, Integrated Workflows

The landscape is shifting from isolated proof-of-concept projects toward AI embedded in end-to-end workflows. Organizations are prioritizing validated use cases, interoperable data foundations, model monitoring, human oversight, and documentation of performance across diverse populations. Regulatory expectations are also moving toward lifecycle governance, transparency, traceability, risk classification, and post-deployment surveillance, making operational controls as important as technical capability.

AI’s Cumulative Impact Across the Life Sciences Value Chain

AI is influencing target identification, molecular design, biomarker discovery, clinical-trial recruitment, protocol optimization, medical imaging, pharmacovigilance, supply planning, and laboratory automation. Generative AI can assist with scientific literature review, coding, documentation, and knowledge retrieval, while predictive models can identify patterns that are difficult to detect manually. Benefits are constrained when datasets are incomplete, biased, poorly labeled, or disconnected across institutions, so human review and prospective validation remain essential.

Regional Insights: Uneven Adoption Shaped by Data, Regulation, and Infrastructure

North America combines strong research capacity, advanced digital infrastructure, and active clinical and commercial experimentation. Europe emphasizes privacy, trustworthy AI, cross-border data governance, and regulatory accountability. Asia-Pacific is characterized by substantial research activity, expanding digital health systems, and varied national approaches to data and medical-device oversight. The Middle East is investing in digital transformation and specialized healthcare capabilities, while Africa is applying AI selectively where it can strengthen diagnostics, public-health monitoring, and service access. Latin America is advancing through health-system digitization and research partnerships, with implementation shaped by connectivity, funding, and data-governance constraints.

Group Insights: Cooperation and Governance Define Strategic Readiness

ASEAN members face varied digital maturity and are focusing on interoperable health information, regional collaboration, and practical applications that address access and capacity gaps. BRICS economies bring large and diverse populations, substantial scientific resources, and differing regulatory environments, creating both collaboration opportunities and governance complexity. The European Union is centered on harmonized rules, privacy protection, and trustworthy deployment. G7 members generally combine advanced research ecosystems with strong expectations for safety, accountability, and standards. GCC countries are emphasizing digitally enabled healthcare and national innovation programs. NATO members are increasingly attentive to resilience, cybersecurity, dual-use risks, and secure data infrastructure.

Country Insights: Distinct National Priorities and Capability Profiles

The United States is advancing AI across biomedical research, clinical operations, and healthcare delivery, with attention to safety and regulatory oversight. Canada emphasizes responsible innovation, public-sector research, and health-data governance. The United Kingdom is developing AI-enabled life-science capabilities alongside evidence and safety frameworks. France, Germany, Italy, and Spain are combining European governance requirements with national research, industrial, and healthcare priorities. Australia is applying AI across research, remote care, and health-system modernization. China is pursuing broad integration of AI with biotechnology, manufacturing, and healthcare under evolving governance controls. Japan and South Korea are focusing on robotics, precision medicine, advanced manufacturing, and aging-related care needs. India is applying AI to diagnostics, pharmaceutical research, and scalable healthcare delivery. Brazil and Mexico are building use cases around public health, clinical services, and research while addressing data quality and infrastructure differences. Russia retains scientific and technical capabilities but operates within distinct institutional, regulatory, and international-access conditions.

Action Priorities for Life Sciences Leaders

Leaders should begin with clearly defined clinical or scientific problems, measurable outcomes, and risk-based validation requirements rather than technology-first experimentation. They should establish accountable governance covering data provenance, privacy, bias testing, cybersecurity, model monitoring, intellectual property, and human escalation. Investments should prioritize interoperable data architecture, high-quality annotation, workforce training, and partnerships that enable independent validation. Deployment plans should include prospective performance evaluation, change-control procedures, user feedback, and transparent communication with regulators, clinicians, researchers, patients, and other affected stakeholders.

Research Methodology: Evidence-Led Market Assessment

This executive summary synthesizes verified public-domain evidence on artificial intelligence applications in life sciences, including regulatory publications, government and intergovernmental materials, peer-reviewed research, clinical and scientific literature, standards guidance, and documented industry practices. Findings were organized across the life-sciences value chain and compared by geography and economic or institutional grouping. Claims were screened for relevance, consistency, and evidentiary support; where adoption conditions differ materially, the narrative identifies the underlying drivers such as infrastructure, regulation, data availability, research capacity, and workforce readiness.

Conclusion: Responsible Integration Is the Competitive Differentiator

Artificial intelligence is becoming a foundational capability in life sciences, but durable value will depend on disciplined integration rather than experimentation alone. Organizations that combine high-quality data, scientific validation, secure infrastructure, regulatory fluency, and human-centered implementation will be better positioned to translate AI advances into reliable outcomes. Regional and national differences make adaptable governance essential, while continued collaboration across researchers, healthcare professionals, regulators, technology specialists, and patients will shape the sector’s responsible evolution.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Artificial Intelligence in Life Sciences Market, by Component
7.1. Introduction
7.2. Hardware
7.2.1. Processors & Accelerators
7.2.2. Servers & Workstations
7.2.3. Storage & Networking
7.3. Services
7.3.1. Consulting
7.3.2. Integration
7.3.3. Support & Maintenance
7.4. Software
7.4.1. Platforms
7.4.2. Solutions
7.4.3. Tools & Frameworks
8. Artificial Intelligence in Life Sciences Market, by Data Type
8.1. Introduction
8.2. Clinical Data
8.2.1. Electronic Health Records
8.2.2. Lab Results
8.3. Genomic Data
8.3.1. Gene Expression Data
8.3.2. Sequencing Data
8.4. Imaging Data
8.4.1. CT Scans
8.4.2. MRI
8.4.3. Ultrasound
8.4.4. X Ray
9. Artificial Intelligence in Life Sciences Market, by Deployment
9.1. Introduction
9.2. Cloud
9.2.1. Hybrid Cloud
9.2.2. Private Cloud
9.2.3. Public Cloud
9.3. On Premise
10. Artificial Intelligence in Life Sciences Market, by Technology
10.1. Introduction
10.2. Computer Vision
10.2.1. 3D Reconstruction
10.2.2. Medical Imaging Analysis
10.2.3. Pattern Recognition
10.3. Machine Learning
10.3.1. Deep Learning
10.3.2. Reinforcement Learning
10.3.3. Supervised Learning
10.3.4. Unsupervised Learning
10.4. Natural Language Processing
10.4.1. Semantic Analysis
10.4.2. Speech Recognition
10.4.3. Text Mining
10.5. Predictive Analytics
10.5.1. Outcome Prediction
10.5.2. Risk Modeling
10.6. Robotic Process Automation
11. Artificial Intelligence in Life Sciences Market, by End User
11.1. Introduction
11.2. Contract Research Organizations
11.3. Healthcare Providers
11.3.1. Clinics
11.3.2. Diagnostic Centers
11.3.3. Hospitals
11.4. Pharmaceutical & Biotechnology Companies
11.5. Research Organizations
12. Artificial Intelligence in Life Sciences Market, by Application
12.1. Introduction
12.2. Clinical Trial Management
12.2.1. Data Management
12.2.2. Patient Recruitment
12.2.3. Trial Design
12.3. Diagnostics & Imaging
12.3.1. Genomic Imaging
12.3.2. Pathology Imaging
12.3.3. Radiology Imaging
12.4. Drug Discovery
12.4.1. Lead Optimization
12.4.2. Target Identification
12.4.3. Toxicology Prediction
12.5. Patient Monitoring
12.5.1. Remote Monitoring
12.5.2. Wearable Devices
12.6. Treatment Personalization
12.6.1. Dose Optimization
12.6.2. Precision Medicine
13. Artificial Intelligence in Life Sciences Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Artificial Intelligence in Life Sciences Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Artificial Intelligence in Life Sciences Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Atomwise
17.2. BenevolentAI
17.3. BioAge Labs
17.4. Cyclica
17.5. Exscientia
17.6. GNS Healthcare
17.7. Google Health
17.8. Healx
17.9. IBM Watson Health
17.10. Iktos
17.11. Insilico Medicine
17.12. Microsoft Corporation
17.13. NVIDIA Corporation
17.14. PathAI
17.15. Recursion Pharmaceuticals
17.16. ReviveMed
17.17. Schrödinger, Inc.
17.18. SOPHiA GENETICS
17.19. Standigm
17.20. Tempus Labs
17.21. Valo Health
17.22. Verily Life Sciences
17.23. XtalPi
17.24. Zephyr AI
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Artificial Intelligence in Life Sciences Market, Years Considered for the Study
FIGURE 2. Global Artificial Intelligence in Life Sciences Market, Research Design
FIGURE 3. Global Artificial Intelligence in Life Sciences Market, Research Framework
FIGURE 4. Global Artificial Intelligence in Life Sciences Market, Data Triangulation
FIGURE 5. Global Artificial Intelligence in Life Sciences Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Artificial Intelligence in Life Sciences Market Size, by Component, 2025 vs 2032 (%)
FIGURE 7. Global Artificial Intelligence in Life Sciences Market Size, by Component, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Artificial Intelligence in Life Sciences Market Size, by Data Type, 2025 vs 2032 (%)
FIGURE 9. Global Artificial Intelligence in Life Sciences Market Size, by Data Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Artificial Intelligence in Life Sciences Market Size, by Deployment, 2025 vs 2032 (%)
FIGURE 11. Global Artificial Intelligence in Life Sciences Market Size, by Deployment, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Artificial Intelligence in Life Sciences Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 13. Global Artificial Intelligence in Life Sciences Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Artificial Intelligence in Life Sciences Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Artificial Intelligence in Life Sciences Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Artificial Intelligence in Life Sciences Market Size, by Application, 2025 vs 2032 (%)
FIGURE 17. Global Artificial Intelligence in Life Sciences Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Artificial Intelligence in Life Sciences Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Artificial Intelligence in Life Sciences Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Artificial Intelligence in Life Sciences Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Artificial Intelligence in Life Sciences Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Artificial Intelligence in Life Sciences Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Artificial Intelligence in Life Sciences Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Artificial Intelligence in Life Sciences Market Segmentation & Coverage
TABLE 2. Global Artificial Intelligence in Life Sciences Market Size, 2017-2032 (USD Million)
TABLE 3. Global Artificial Intelligence in Life Sciences Market Size, by Component, 2017-2032 (USD Million)
TABLE 4. Global Hardware Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Hardware Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Hardware Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Processors & Accelerators Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Processors & Accelerators Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Processors & Accelerators Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Servers & Workstations Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Servers & Workstations Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Servers & Workstations Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Storage & Networking Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Storage & Networking Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Storage & Networking Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Consulting Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Consulting Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Consulting Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Integration Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Integration Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Integration Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Support & Maintenance Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Support & Maintenance Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Support & Maintenance Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Solutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Solutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Tools & Frameworks Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Tools & Frameworks Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Tools & Frameworks Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Artificial Intelligence in Life Sciences Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 41. Global Clinical Data Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Clinical Data Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Clinical Data Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Electronic Health Records Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Electronic Health Records Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Electronic Health Records Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Lab Results Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Lab Results Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Lab Results Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Genomic Data Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Genomic Data Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Genomic Data Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Gene Expression Data Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Gene Expression Data Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Gene Expression Data Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Sequencing Data Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Sequencing Data Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Sequencing Data Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Imaging Data Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Imaging Data Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Imaging Data Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global CT Scans Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global CT Scans Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global CT Scans Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global MRI Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global MRI Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global MRI Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Ultrasound Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Ultrasound Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Ultrasound Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global X Ray Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global X Ray Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global X Ray Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Artificial Intelligence in Life Sciences Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 75. Global Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Hybrid Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Hybrid Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Hybrid Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Private Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Private Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Private Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Public Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Public Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Public Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global On Premise Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global On Premise Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global On Premise Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Artificial Intelligence in Life Sciences Market Size, by Technology, 2017-2032 (USD Million)
TABLE 91. Global Computer Vision Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Computer Vision Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Computer Vision Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global 3D Reconstruction Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global 3D Reconstruction Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global 3D Reconstruction Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Medical Imaging Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Medical Imaging Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Medical Imaging Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Pattern Recognition Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Pattern Recognition Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Pattern Recognition Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Machine Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Machine Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Machine Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Deep Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Deep Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Deep Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Reinforcement Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Reinforcement Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Reinforcement Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Supervised Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Supervised Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Supervised Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Unsupervised Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Unsupervised Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Unsupervised Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Natural Language Processing Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Natural Language Processing Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Natural Language Processing Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Semantic Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Semantic Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Semantic Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Speech Recognition Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Speech Recognition Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Speech Recognition Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Text Mining Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Text Mining Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Text Mining Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Predictive Analytics Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Predictive Analytics Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Predictive Analytics Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Outcome Prediction Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Outcome Prediction Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Outcome Prediction Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Risk Modeling Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Risk Modeling Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Risk Modeling Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Robotic Process Automation Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Robotic Process Automation Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Robotic Process Automation Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Artificial Intelligence in Life Sciences Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Healthcare Providers Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Global Healthcare Providers Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. Global Healthcare Providers Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 161. Global Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Global Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. Global Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. Global Artificial Intelligence in Life Sciences Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. Global Clinical Trial Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 166. Global Clinical Trial Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. Global Clinical Trial Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 168. Global Data Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Global Data Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. Global Data Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 171. Global Patient Recruitment Market Size, by Region, 2017-2032 (USD Million)
TABLE 172. Global Patient Recruitment Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. Global Patient Recruitment Market Size, by Country, 2017-2032 (USD Million)
TABLE 174. Global Trial Design Market Size, by Region, 2017-2032 (USD Million)
TABLE 175. Global Trial Design Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. Global Trial Design Market Size, by Country, 2017-2032 (USD Million)
TABLE 177. Global Diagnostics & Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 178. Global Diagnostics & Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. Global Diagnostics & Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 180. Global Genomic Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 181. Global Genomic Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. Global Genomic Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 183. Global Pathology Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 184. Global Pathology Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. Global Pathology Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 186. Global Radiology Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Global Radiology Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. Global Radiology Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 189. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 190. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 192. Global Lead Optimization Market Size, by Region, 2017-2032 (USD Million)
TABLE 193. Global Lead Optimization Market Size, by Group, 2017-2032 (USD Million)
TABLE 194. Global Lead Optimization Market Size, by Country, 2017-2032 (USD Million)
TABLE 195. Global Target Identification Market Size, by Region, 2017-2032 (USD Million)
TABLE 196. Global Target Identification Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. Global Target Identification Market Size, by Country, 2017-2032 (USD Million)
TABLE 198. Global Toxicology Prediction Market Size, by Region, 2017-2032 (USD Million)
TABLE 199. Global Toxicology Prediction Market Size, by Group, 2017-2032 (USD Million)
TABLE 200. Global Toxicology Prediction Market Size, by Country, 2017-2032 (USD Million)
TABLE 201. Global Patient Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 202. Global Patient Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 203. Global Patient Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 204. Global Remote Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 205. Global Remote Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 206. Global Remote Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 207. Global Wearable Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 208. Global Wearable Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 209. Global Wearable Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 210. Global Treatment Personalization Market Size, by Region, 2017-2032 (USD Million)
TABLE 211. Global Treatment Personalization Market Size, by Group, 2017-2032 (USD Million)
TABLE 212. Global Treatment Personalization Market Size, by Country, 2017-2032 (USD Million)
TABLE 213. Global Dose Optimization Market Size, by Region, 2017-2032 (USD Million)
TABLE 214. Global Dose Optimization Market Size, by Group, 2017-2032 (USD Million)
TABLE 215. Global Dose Optimization Market Size, by Country, 2017-2032 (USD Million)
TABLE 216. Global Precision Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 217. Global Precision Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 218. Global Precision Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 219. Global Artificial Intelligence in Life Sciences Market Size, by Region, 2017-2032 (USD Million)
TABLE 220. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Region, 2017-2032 (USD Million)
TABLE 221. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Component, 2017-2032 (USD Million)
TABLE 222. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 223. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Services, 2017-2032 (USD Million)
TABLE 224. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Software, 2017-2032 (USD Million)
TABLE 225. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 226. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Clinical Data, 2017-2032 (USD Million)
TABLE 227. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Genomic Data, 2017-2032 (USD Million)
TABLE 228. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Imaging Data, 2017-2032 (USD Million)
TABLE 229. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 230. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 231. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Technology, 2017-2032 (USD Million)
TABLE 232. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Computer Vision, 2017-2032 (USD Million)
TABLE 233. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 234. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Natural Language Processing, 2017-2032 (USD Million)
TABLE 235. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Predictive Analytics, 2017-2032 (USD Million)
TABLE 236. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 238. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Application, 2017-2032 (USD Million)
TABLE 239. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Clinical Trial Management, 2017-2032 (USD Million)
TABLE 240. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Diagnostics & Imaging, 2017-2032 (USD Million)
TABLE 241. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 242. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Patient Monitoring, 2017-2032 (USD Million)
TABLE 243. Asia-Pacific Artificial Intelligence in Life Sciences Market Size, by Treatment Personalization, 2017-2032 (USD Million)
TABLE 244. North America Artificial Intelligence in Life Sciences Market Size, by Region, 2017-2032 (USD Million)
TABLE 245. North America Artificial Intelligence in Life Sciences Market Size, by Component, 2017-2032 (USD Million)
TABLE 246. North America Artificial Intelligence in Life Sciences Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 247. North America Artificial Intelligence in Life Sciences Market Size, by Services, 2017-2032 (USD Million)
TABLE 248. North America Artificial Intelligence in Life Sciences Market Size, by Software, 2017-2032 (USD Million)
TABLE 249. North America Artificial Intelligence in Life Sciences Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 250. North America Artificial Intelligence in Life Sciences Market Size, by Clinical Data, 2017-2032 (USD Million)
TABLE 251. North America Artificial Intelligence in Life Sciences Market Size, by Genomic Data, 2017-2032 (USD Million)
TABLE 252. North America Artificial Intelligence in Life Sciences Market Size, by Imaging Data, 2017-2032 (USD Million)
TABLE 253. North America Artificial Intelligence in Life Sciences Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 254. North America Artificial Intelligence in Life Sciences Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 255. North America Artificial Intelligence in Life Sciences Market Size, by Technology, 2017-2032 (USD Million)
TABLE 256. North America Artificial Intelligence in Life Sciences Market Size, by Computer Vision, 2017-2032 (USD Million)
TABLE 257. North America Artificial Intelligence in Life Sciences Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 258. North America Artificial Intelligence in Life Sciences Market Size, by Natural Language Processing, 2017-2032 (USD Million)
TABLE 259. North America Artificial Intelligence in Life Sciences Market Size, by Predictive Analytics, 2017-2032 (USD Million)
TABLE 260. North America Artificial Intelligence in Life Sciences Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. North America Artificial Intelligence in Life Sciences Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 262. North America Artificial Intelligence in Life Sciences Market Size, by Application, 2017-2032 (USD Million)
TABLE 263. North America Artificial Intelligence in Life Sciences Market Size, by Clinical Trial Management, 2017-2032 (USD Million)
TABLE 264. North America Artificial Intelligence in Life Sciences Market Size, by Diagnostics & Imaging, 2017-2032 (USD Million)
TABLE 265. North America Artificial Intelligence in Life Sciences Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 266. North America Artificial Intelligence in Life Sciences Market Size, by Patient Monitoring, 2017-2032 (USD Million)
TABLE 267. North America Artificial Intelligence in Life Sciences Market Size, by Treatment Personalization, 2017-2032 (USD Million)
TABLE 268. Latin America Artificial Intelligence in Life Sciences Market Size, by Region, 2017-2032 (USD Million)
TABLE 269. Latin America Artificial Intelligence in Life Sciences Market Size, by Component, 2017-2032 (USD Million)
TABLE 270. Latin America Artificial Intelligence in Life Sciences Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 271. Latin America Artificial Intelligence in Life Sciences Market Size, by Services, 2017-2032 (USD Million)
TABLE 272. Latin America Artificial Intelligence in Life Sciences Market Size, by Software, 2017-2032 (USD Million)
TABLE 273. Latin America Artificial Intelligence in Life Sciences Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 274. Latin America Artificial Intelligence in Life Sciences Market Size, by Clinical Data, 2017-2032 (USD Million)
TABLE 275. Latin America Artificial Intelligence in Life Sciences Market Size, by Genomic Data, 2017-2032 (USD Million)
TABLE 276. Latin America Artificial Intelligence in Life Sciences Market Size, by Imaging Data, 2017-2032 (USD Million)
TABLE 277. Latin America Artificial Intelligence in Life Sciences Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 278. Latin America Artificial Intelligence in Life Sciences Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 279. Latin America Artificial Intelligence in Life Sciences Market Size, by Technology, 2017-2032 (USD Million)
TABLE 280. Latin America Artificial Intelligence in Life Sciences Market Size, by Computer Vision, 2017-2032 (USD Million)
TABLE 281. Latin America Artificial Intelligence in Life Sciences Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 282. Latin America Artificial Intelligence in Life Sciences Market Size, by Natural Language Processing, 2017-2032 (USD Million)
TABLE 283. Latin America Artificial Intelligence in Life Sciences Market Size, by Predictive Analytics, 2017-2032 (USD Million)
TABLE 284. Latin America Artificial Intelligence in Life Sciences Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. Latin America Artificial Intelligence in Life Sciences Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 286. Latin America Artificial Intelligence in Life Sciences Market Size, by Application, 2017-2032 (USD Million)
TABLE 287. Latin America Artificial Intelligence in Life Sciences Market Size, by Clinical Trial Management, 2017-2032 (USD Million)
TABLE 288. Latin America Artificial Intelligence in Life Sciences Market Size, by Diagnostics & Imaging, 2017-2032 (USD Million)
TABLE 289. Latin America Artificial Intelligence in Life Sciences Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 290. Latin America Artificial Intelligence in Life Sciences Market Size, by Patient Monitoring, 2017-2032 (USD Million)
TABLE 291. Latin America Artificial Intelligence in Life Sciences Market Size, by Treatment Personalization, 2017-2032 (USD Million)
TABLE 292. Europe Artificial Intelligence in Life Sciences Market Size, by Region, 2017-2032 (USD Million)
TABLE 293. Europe Artificial Intelligence in Life Sciences Market Size, by Component, 2017-2032 (USD Million)
TABLE 294. Europe Artificial Intelligence in Life Sciences Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 295. Europe Artificial Intelligence in Life Sciences Market Size, by Services, 2017-2032 (USD Million)
TABLE 296. Europe Artificial Intelligence in Life Sciences Market Size, by Software, 2017-2032 (USD Million)
TABLE 297. Europe Artificial Intelligence in Life Sciences Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 298. Europe Artificial Intelligence in Life Sciences Market Size, by Clinical Data, 2017-2032 (USD Million)
TABLE 299. Europe Artificial Intelligence in Life Sciences Market Size, by Genomic Data, 2017-2032 (USD Million)
TABLE 300. Europe Artificial Intelligence in Life Sciences Market Size, by Imaging Data, 2017-2032 (USD Million)
TABLE 301. Europe Artificial Intelligence in Life Sciences Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 302. Europe Artificial Intelligence in Life Sciences Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 303. Europe Artificial Intelligence in Life Sciences Market Size, by Technology, 2017-2032 (USD Million)
TABLE 304. Europe Artificial Intelligence in Life Sciences Market Size, by Computer Vision, 2017-2032 (USD Million)
TABLE 305. Europe Artificial Intelligence in Life Sciences Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 306. Europe Artificial Intelligence in Life Sciences Market Size, by Natural Language Processing, 2017-2032 (USD Million)
TABLE 307. Europe Artificial Intelligence in Life Sciences Market Size, by Predictive Analytics, 2017-2032 (USD Million)
TABLE 308. Europe Artificial Intelligence in Life Sciences Market Size, by End User, 2017-2032 (USD Million)
TABLE 309. Europe Artificial Intelligence in Life Sciences Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 310. Europe Artificial Intelligence in Life Sciences Market Size, by Application, 2017-2032 (USD Million)
TABLE 311. Europe Artificial Intelligence in Life Sciences Market Size, by Clinical Trial Management, 2017-2032 (USD Million)
TABLE 312. Europe Artificial Intelligence in Life Sciences Market Size, by Diagnostics & Imaging, 2017-2032 (USD Million)
TABLE 313. Europe Artificial Intelligence in Life Sciences Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 314. Europe Artificial Intelligence in Life Sciences Market Size, by Patient Monitoring, 2017-2032 (USD Million)
TABLE 315. Europe Artificial Intelligence in Life Sciences Market Size, by Treatment Personalization, 2017-2032 (USD Million)
TABLE 316. Middle East Artificial Intelligence in Life Sciences Market Size, by Region, 2017-2032 (USD Million)
TABLE 317. Middle East Artificial Intelligence in Life Sciences Market Size, by Component, 2017-2032 (USD Million)
TABLE 318. Middle East Artificial Intelligence in Life Sciences Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 319. Middle East Artificial Intelligence in Life Sciences Market Size, by Services, 2017-2032 (USD Million)
TABLE 320. Middle East Artificial Intelligence in Life Sciences Market Size, by Software, 2017-2032 (USD Million)
TABLE 321. Middle East Artificial Intelligence in Life Sciences Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 322. Middle East Artificial Intelligence in Life Sciences Market Size, by Clinical Data, 2017-2032 (USD Million)
TABLE 323. Middle East Artificial Intelligence in Life Sciences Market Size, by Genomic Data, 2017-2032 (USD Million)
TABLE 324. Middle East Artificial Intelligence in Life Sciences Market Size, by Imaging Data, 2017-2032 (USD Million)
TABLE 325. Middle East Artificial Intelligence in Life Sciences Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 326. Middle East Artificial Intelligence in Life Sciences Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 327. Middle East Artificial Intelligence in Life Sciences Market Size, by Technology, 2017-2032 (USD Million)
TABLE 328. Middle East Artificial Intelligence in Life Sciences Market Size, by Computer Vision, 2017-2032 (USD Million)
TABLE 329. Middle East Artificial Intelligence in Life Sciences Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 330. Middle East Artificial Intelligence in Life Sciences Market Size, by Natural Language Processing, 2017-2032 (USD Million)
TABLE 331. Middle East Artificial Intelligence in Life Sciences Market Size, by Predictive Analytics, 2017-2032 (USD Million)
TABLE 332. Middle East Artificial Intelligence in Life Sciences Market Size, by End User, 2017-2032 (USD Million)
TABLE 333. Middle East Artificial Intelligence in Life Sciences Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 334. Middle East Artificial Intelligence in Life Sciences Market Size, by Application, 2017-2032 (USD Million)
TABLE 335. Middle East Artificial Intelligence in Life Sciences Market Size, by Clinical Trial Management, 2017-2032 (USD Million)
TABLE 336. Middle East Artificial Intelligence in Life Sciences Market Size, by Diagnostics & Imaging, 2017-2032 (USD Million)
TABLE 337. Middle East Artificial Intelligence in Life Sciences Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 338. Middle East Artificial Intelligence in Life Sciences Market Size, by Patient Monitoring, 2017-2032 (USD Million)
TABLE 339. Middle East Artificial Intelligence in Life Sciences Market Size, by Treatment Personalization, 2017-2032 (USD Million)
TABLE 340. Africa Artificial Intelligence in Lif

Companies Mentioned

  • Atomwise
  • BenevolentAI
  • BioAge Labs
  • Cyclica
  • Exscientia
  • GNS Healthcare
  • Google Health
  • Healx
  • IBM Watson Health
  • Iktos
  • Insilico Medicine
  • Microsoft Corporation
  • NVIDIA Corporation
  • PathAI
  • Recursion Pharmaceuticals
  • ReviveMed
  • Schrödinger, Inc.
  • SOPHiA GENETICS
  • Standigm
  • Tempus Labs
  • Valo Health
  • Verily Life Sciences
  • XtalPi
  • Zephyr AI